Clinical trial
Feasibility Study of mFOLFOX6 (Oxaliplatin Combined With l-Leucovorin (l-LV) and 5-Fluorouracil) in Patients With Advanced Colorectal Cancer
NCT00209703 is registered in ClinicalTrials.gov with Hokkaido Gastrointestinal Cancer Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of mFOLFOX6 (Oxaliplatin Combined With l-Leucovorin (l-LV) and 5-Fluorouracil) in Patients With Advanced Colorectal Cancer
- Lead sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2005
- Completion date
- June 30, 2007
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer